Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient and disease characteristics of the ITT population (n = 26)

From: A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

Age (years) Median 58   
  Range 34–78   
  Patients  
ECOG performance status    
 0    15 58%
 1    10 38%
 2    1 4%
Primary site:     
 Ovarian    22 85%
 Fallopian tube    1 4%
 Peritoneum    3 11%
Histology     
 Serous    22 85%
 Endometrioid    1 4%
 Endometrioid and clear cell    1 4%
 Other    2 7%
Differentiation     
 Grade 1    -  
 Grade 2    1 4%
 Grade 3    24 92%
 Grade not assigned    1 4%
Tumor expression of mucin 1 by immunohistochemistry
 Positive    23 88%
 Negative    2 8%
 Not assessed    1 4%